Heidi Hagen
Direktor/Vorstandsmitglied bei VERICEL CORPORATION
Vermögen: 847 643 $ am 30.04.2024
Aktive Positionen von Heidi Hagen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERICEL CORPORATION | Direktor/Vorstandsmitglied | 23.08.2013 | - |
Independent Dir/Board Member | 23.08.2013 | - | |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - | - |
A-Alpha Bio, Inc.
A-Alpha Bio, Inc. Packaged SoftwareTechnology Services A-Alpha Bio, Inc. designs and develops a drug discovery platform. The firm offers AlphaSeq platform. The company was founded by Randolph Lopez and David Younger in 2017 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | 27.06.2023 | - |
Independent Dir/Board Member | 27.06.2023 | - |
Karriereverlauf von Heidi Hagen
Ehemalige bekannte Positionen von Heidi Hagen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALAUNOS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 13.06.2019 | 02.11.2021 |
Vorstandsvorsitzender | 25.02.2021 | 30.08.2021 | |
Independent Dir/Board Member | 30.08.2021 | 02.11.2021 | |
Vineti, Inc.
Vineti, Inc. Medical/Nursing ServicesHealth Services Vineti, Inc. develops software for scaling and digital solutions for cell and gene therapies. The firm focuses on enabling life changing autologous therapies, supporting standards, and developing infrastructure that will expand patient access through expedited discovery, delivery and regulation in the field. The company was founded by Heidi Hagen, Malek Faham, Amy DuRoss and Razmik Abnous and is headquartered in San Francisco CA. | Direktor/Vorstandsmitglied | - | 01.02.2021 |
Geschäftsführer | - | - | |
Gründer | - | 01.02.2021 | |
Corporate Officer/Principal | 01.10.2015 | 01.02.2021 | |
ZappRx, Inc.
ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services ZappRx, Inc. develops prescription and prior authorization platform services. It provides healthcare providers, specialty pharmacies, biopharmacies, and security standards solutions. The company was founded by Zoe Barry in 2012 and is headquartered in Boston, MA. | Geschäftsführer | 01.01.2015 | 01.06.2015 |
Sotio LLC | Geschäftsführer | 01.03.2013 | 01.04.2014 |
DENDREON CORPORATION | Geschäftsführer | 01.10.2002 | 01.05.2012 |
Sotio Biotech AS
Sotio Biotech AS BiotechnologyHealth Technology Sotio Biotech AS is a member of the PPF Group and is based in Prague, Czechia. The Czech company is focused on developing cancer immunotherapies and has a robust clinical pipeline that includes a differentiated superagonist of the immuno-oncology target IL-15, currently being tested in phase II clinical trials. The pipeline also includes SOT102, a next-generation claudin-18.2-targeted antibody-drug conjugate, BOXR1030, a metabolically-enhanced CAR-T cell therapy targeting GPC3-expressing tumors, and other molecules approaching clinical stage such as SOT201, a next-generation PD-1-inhibiting cytokine. Three programs will enter phase I clinical testing within the next 12 months, including SOT201, BOXR1030, and SOT102. | Geschäftsführer | - | - |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Heidi Hagen
University of Washington | Graduate Degree |
Statistik
International
Vereinigte Staaten | 12 |
Tschechische Republik | 2 |
Operativ
Director/Board Member | 6 |
Chief Operating Officer | 5 |
Independent Dir/Board Member | 3 |
Sektoral
Health Technology | 7 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VERICEL CORPORATION | Health Technology |
ALAUNOS THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 9 |
---|---|
Sotio LLC | |
Vineti, Inc.
Vineti, Inc. Medical/Nursing ServicesHealth Services Vineti, Inc. develops software for scaling and digital solutions for cell and gene therapies. The firm focuses on enabling life changing autologous therapies, supporting standards, and developing infrastructure that will expand patient access through expedited discovery, delivery and regulation in the field. The company was founded by Heidi Hagen, Malek Faham, Amy DuRoss and Razmik Abnous and is headquartered in San Francisco CA. | Health Services |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
ZappRx, Inc.
ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services ZappRx, Inc. develops prescription and prior authorization platform services. It provides healthcare providers, specialty pharmacies, biopharmacies, and security standards solutions. The company was founded by Zoe Barry in 2012 and is headquartered in Boston, MA. | Commercial Services |
Lykan Biosciences LLC | |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Health Technology |
Sotio Biotech AS
Sotio Biotech AS BiotechnologyHealth Technology Sotio Biotech AS is a member of the PPF Group and is based in Prague, Czechia. The Czech company is focused on developing cancer immunotherapies and has a robust clinical pipeline that includes a differentiated superagonist of the immuno-oncology target IL-15, currently being tested in phase II clinical trials. The pipeline also includes SOT102, a next-generation claudin-18.2-targeted antibody-drug conjugate, BOXR1030, a metabolically-enhanced CAR-T cell therapy targeting GPC3-expressing tumors, and other molecules approaching clinical stage such as SOT201, a next-generation PD-1-inhibiting cytokine. Three programs will enter phase I clinical testing within the next 12 months, including SOT201, BOXR1030, and SOT102. | Health Technology |
A-Alpha Bio, Inc.
A-Alpha Bio, Inc. Packaged SoftwareTechnology Services A-Alpha Bio, Inc. designs and develops a drug discovery platform. The firm offers AlphaSeq platform. The company was founded by Randolph Lopez and David Younger in 2017 and is headquartered in Seattle, WA. | Technology Services |
- Börse
- Insiders
- Heidi Hagen
- Erfahrung